YU12404A - Ekstrakt lista artičoke - Google Patents

Ekstrakt lista artičoke

Info

Publication number
YU12404A
YU12404A YU12404A YUP12404A YU12404A YU 12404 A YU12404 A YU 12404A YU 12404 A YU12404 A YU 12404A YU P12404 A YUP12404 A YU P12404A YU 12404 A YU12404 A YU 12404A
Authority
YU
Yugoslavia
Prior art keywords
leaf extracts
artichoke
extracts
artichoke leaf
percentages
Prior art date
Application number
YU12404A
Other languages
English (en)
Inventor
Jurgen Eich
Thomas Haffner
Thomas Goerke
Werner Schneider
Original Assignee
Lichtwer Pharma Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lichtwer Pharma Ag. filed Critical Lichtwer Pharma Ag.
Publication of YU12404A publication Critical patent/YU12404A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Neurology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Birds (AREA)
  • Hospice & Palliative Care (AREA)
  • Medical Informatics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)

Abstract

Pronalazak se odnosi na ekstrakte listova artičoka (Cynarae folium) koji su okarakterisani definisanim apsolutnim procentima i relativnim bitnim procentima tipičnih sastojaka listova artičoka, kao što su kafeolil kvinične kiseline i flavonoidi. Spektar aktivnosti otkrivenih ekstrakata listova je značajno različit od poznatih ekstrakata listova artičoka. Pomenuti otkriveni ekstrakti takođe su različiti jedan od drugog. Pronalazak se takođe odnosi na postupke za proizvodnju ekstrakata i na oblasti njihove primene.[The invention relates to artichoke leaf extracts (Cynarae folium) that are characterized by defined absolute percentages and relative inherent percentages of typical constituents of artichoke leaves such as caffeoyl quinic acids and flavonoids The activity spectrum of the inventive leaf extracts is substantially different from known artichoke leaf extracts, said inventive leaf extracts also being different from each other. The invention also relates to methods for producing the extracts and to fields of application thereof.
YU12404A 2001-08-08 2002-08-07 Ekstrakt lista artičoke YU12404A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10138929A DE10138929A1 (de) 2001-08-08 2001-08-08 Artischockenblätterextrakte

Publications (1)

Publication Number Publication Date
YU12404A true YU12404A (sh) 2006-08-17

Family

ID=7694791

Family Applications (1)

Application Number Title Priority Date Filing Date
YU12404A YU12404A (sh) 2001-08-08 2002-08-07 Ekstrakt lista artičoke

Country Status (13)

Country Link
US (1) US20040234674A1 (sh)
EP (1) EP1416950A1 (sh)
JP (1) JP2004537578A (sh)
CA (1) CA2455761A1 (sh)
DE (2) DE10138929A1 (sh)
HR (1) HRPK20040225B3 (sh)
HU (1) HUP0600153A3 (sh)
IL (2) IL160083A0 (sh)
MX (1) MXPA04001115A (sh)
NO (1) NO20040979L (sh)
PL (1) PL205013B1 (sh)
WO (1) WO2003013562A1 (sh)
YU (1) YU12404A (sh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1301721C (zh) * 2003-07-23 2007-02-28 昆明英之源农业科技开发有限公司 朝鲜蓟天然抗氧化剂及其提取方法
FR2883472B1 (fr) * 2005-03-23 2010-09-03 Rocher Yves Biolog Vegetale Utilisation d'un acide chlorogenique en tant qu'un actif amincissant
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
DE102006031762A1 (de) 2006-07-05 2008-01-10 Lancaster Group Gmbh Kosmetische Zubereitung mit einem Hautpflegekomplex mit Anti-Alterungswirkung
JP2008148658A (ja) * 2006-12-20 2008-07-03 Kansai:Kk アーティチョーク飴及び薬膳用食材
ITRM20070109A1 (it) 2007-02-28 2008-09-01 Massimo Pizzichini Procedimento per la produzione di estratti nutraceutici raffinati dai residui del carciofo e da altre piante del genere cynara.
FI123498B (fi) * 2008-07-01 2013-05-31 Upm Kymmene Oyj Menetelmä oksapuu-uutteen fraktioimiseksi ja neste-nesteuuton käyttö oksapuu-uutteen puhdistamiseksi
FR2936711B1 (fr) * 2008-10-06 2012-09-21 Holymark Composition orale, en particulier complement alimentaire comprenant un extrait sec de feuilles d'artichaut et de la levure de riz rouge
KR101762388B1 (ko) * 2009-01-20 2017-07-28 인데나 에스.피.에이 식도 역류 및 과민성 장 증후군의 예방 및 치료에 유용한, 생강의 친유성 추출물 및 시나라 스콜리무스의 추출물을 포함하는 조성물
IT1395119B1 (it) * 2009-07-29 2012-09-05 Indena Spa Composizioni a base di estratto lipofilo di zingiber officinale e di estratto di cynara scolymus per la prevenzione e il trattamento del riflusso esofageo e della sindrome del colon irritabile
ITMI20090814A1 (it) * 2009-05-12 2010-11-13 Biofarmitalia Spa Estratto delle parti aeree del carciofo e relativo metodo di produzione
JP2011148708A (ja) * 2010-01-19 2011-08-04 Noevir Co Ltd 保湿剤、抗老化剤、抗酸化剤、痩身剤、美白剤、抗炎症剤、免疫賦活剤、皮膚外用剤及び機能性経口組成物
JP2011207815A (ja) * 2010-03-30 2011-10-20 Cci Corp 抗酸化ストレス剤
CN103327999B (zh) * 2011-01-21 2016-08-10 狮王株式会社 促进脂肪分解组合物
ITMI20111670A1 (it) 2011-09-16 2013-03-17 Indena Spa Estratti di cynara scolimus per il trattamento di dislipidemie
JP2013194007A (ja) * 2012-03-21 2013-09-30 Cci Corp 抗酸化ストレス剤およびその用途
WO2014008901A2 (ar) * 2012-06-27 2014-01-16 Atawia Ahmed Ahmed Rezk Elsaid استخدام الخرشوف الصحراوي في القضاء على الألتهاب الكبدى الوبائى (فيروس سى)
FR3027228B1 (fr) * 2014-10-20 2016-12-09 Valbiotis Composition comprenant un melange d'extraits vegetaux et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
CN106999525A (zh) * 2014-11-25 2017-08-01 阿波卡-阿格里科拉共同股份公司 用于治疗间皮瘤的菜蓟滴定提取物
FR3042411B1 (fr) * 2015-10-20 2019-07-12 Valbiotis Composition comprenant un melange de molecules particulieres et utilisation pour agir sur le metabolisme glucidique et/ou lipidique
ES2569132B1 (es) 2015-12-31 2017-02-15 Hidroxicinamics, S.L. Método para la obtención de extractos que comprenden compuestos hidroxicinamicos a partir de residuos vegetales
CN106496033A (zh) * 2016-10-17 2017-03-15 汇美农业科技有限公司 一种朝鲜蓟中1,5‑二咖啡酰奎宁酸的提取方法
FR3075570B1 (fr) * 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
WO2020209429A1 (ko) * 2019-04-12 2020-10-15 주식회사 비엔지삶 팔미라팜 및 아티초크의 생리활성성분을 포함하는 인삼 정과 및 이의 제조 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE538205A (sh) * 1954-05-28 1955-06-15
GB1195050A (en) * 1966-09-23 1970-06-17 Ile De Rech Pharma Et Therapeu Method of Obtaining Depsides and Flavonoids Contained in Plants.
SU644771A1 (ru) * 1977-06-15 1979-01-30 Харьковский Научно-Исследовательский Химико-Фармацевтический Институт Способ получени полифенолов
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
EP0958828A1 (de) * 1998-05-22 1999-11-24 Greither, Peter Präparat auf der Basis der Artischockenpflanze, insbesondere zur Verwendung als Arzneimittel oder Nahrungsergänzungsmittel

Also Published As

Publication number Publication date
CA2455761A1 (en) 2003-02-20
HUP0600153A3 (en) 2011-03-28
NO20040979L (no) 2004-03-05
US20040234674A1 (en) 2004-11-25
DE10164893B4 (de) 2008-08-28
PL368184A1 (en) 2005-03-21
HRPK20040225B3 (en) 2006-07-31
IL160083A0 (en) 2004-06-20
JP2004537578A (ja) 2004-12-16
MXPA04001115A (es) 2005-02-17
HUP0600153A2 (en) 2006-06-28
DE10138929A1 (de) 2003-02-27
IL160083A (en) 2010-11-30
PL205013B1 (pl) 2010-03-31
EP1416950A1 (de) 2004-05-12
WO2003013562A1 (de) 2003-02-20
HRP20040225A2 (en) 2005-04-30

Similar Documents

Publication Publication Date Title
YU12404A (sh) Ekstrakt lista artičoke
WO2003037886A3 (en) Heteroaromatic carboxamide derivatives for the treatment of inflammation
CA2460939A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU2002258066A1 (en) Dermatological and cosmetic compositions
AU2003202159A1 (en) Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
WO2000054753A3 (en) Novel tablets incorporating isoflavone plant extracts and methods of manufacturing them
WO2005112965A3 (en) Botanical anti-inflammatory compositions and methods
MXPA04002070A (es) Compuestos de indazol sustituidos para el tratamiento de la inflamacion.
WO2000010507A3 (en) Use of melanin for inhibition of angiogenesis and macular degeneration
WO2001076640A3 (en) Chemically modified novel erythropoietin stimulating protein compositions and methods
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
MXPA05011949A (es) Metodo para depositar particulas brillantes sobre superficies queratinosas a partir de composiciones que se retiran por enjuague.
WO2002008190A3 (de) Neue heteroaryl-derivate und deren verwendung als antitumormittel
WO2003055444A3 (en) Resveratrol analogues
EP1397127B8 (en) Solid pharmaceutucal formulations comprising modafinil
BG106202A (en) Method of increasing the content of flavonoids and phenolic substances in plants
WO2003027075A3 (en) Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation
WO2005044201A3 (en) Ph sensitive prodrugs of 2,6-diisopropylphenol
WO2000044344A3 (de) Antioxidative hautpflegemittel
WO2004002507A8 (en) Herbal composition for treating or alleviating vascular headaches, neurological conditions and neurodegenerative diseases
WO2004073675A8 (de) Kosmetische zusammensetzung mit whitening-effekt, verfahren zu ihrer herstellung und ihre verwendung
AU2003236817A1 (en) Plant extracts
MXPA02009761A (es) Mejoramiento de jugo de naranja con polvo de flavedo.
WO2002062334A3 (en) Cancer chemopreventative compounds and compositions and methods of treating cancers
CA2485298A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation